Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive-disease small cell lung cancer in the elderly and patients with poor performance status-Reference-Cited by-同舟云学术

Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive-disease small cell lung cancer in the elderly and patients with poor performance status

Published:2018-06-05 Issue:8 Volume:9 Page:967-973
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Igawa Satoshi¹^ORCID,Shirasawa Masayuki¹,Ozawa Takahiro¹,Nishinarita Noriko¹,Okuma Yuriko¹,Ono Taihei¹,Sugimoto Ai¹,Kurahayashi Shintaro¹,Sugita Keisuke¹,Sone Hideyuki¹,Fukui Tomoya¹,Mitsufuji Hisashi²,Kubota Masaru¹,Katagiri Masato³,Sasaki Jiichiro⁴,Naoki Katsuhiko¹

Affiliation:

1. Department of Respiratory Medicine; Kitasato University School of Medicine; Sagamihara Japan

2. Kitasato University School of Nursing; Sagamihara Japan

3. School of Allied Health Sciences, Kitasato University; Sagamihara Japan

4. Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine; Sagamihara Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12772/fullpdf

Reference31 articles.